All In MedTech

FDA Clearance Tracker · K813221

TOXOELISA TEST KIT

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jan 26, 1982 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

The decision

FDA number
K813221
Device name
TOXOELISA TEST KIT
Applicant location
Mchenry, IL
Received
Nov 9, 1981
Decided
Jan 26, 1982
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 866.3780

Every decision under product code LGD

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for M.A. Bioproducts

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.